Impact of antipsychotic medication on the cost of schizophrenia

Expert Review of Pharmacoeconomics & Outcomes Research
Reinhold Kilian, Thomas Becker

Abstract

A systematic literature search regarding the factors influencing the costs of schizophrenia and of comparative studies on the impact of antipsychotic treatment on the costs of schizophrenia between 1990 and 2004 was conducted. Altogether, 11 studies on factors influencing the costs of schizophrenia and 39 pharmacoeconomic studies on the comparative effects of antipsychotic medications on costs of schizophrenia were identified. Considering the factors influencing the costs of schizophrenia, the results of the review revealed only little systematic knowledge due to a great variation of methodologic standards and variables included. With regard to the effects of antipsychotic treatment, most studies compared atypical with conventional antipsychotic compounds. Results of these studies are inconsistent, and due to differences in methodologic standards, it is not possible to draw an evidence-based conclusion on the economic effects of a particular type of antipsychotic treatment. Consensus on the main outcome indicators of antipsychotic treatment and common standards of outcome measurement as well as economic analysis methods are necessary to overcome the current lack of empirical evidence.

References

Jan 1, 1991·Schizophrenia Bulletin·H Häfner, W an der Heiden
Nov 1, 1990·Psychological Medicine·M Knapp, J Beecham
Jan 1, 1989·Hospital & Community Psychiatry·H Häfner, W an der Heiden
Jan 1, 1995·Schizophrenia Bulletin·S M Evers, A J Ament
Jul 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·H J Salize, W Rössler
Aug 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·K J Aitchison, R W Kerwin
Jan 28, 1998·Clinical Therapeutics·C Langley-Hawthorne
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·M Knapp
Apr 2, 1998·Clinical Therapeutics·A DaviesI Schweitzer
Jun 20, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·S N GhaemiF K Goodwin
Aug 26, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·D J LuchinsC G Fichtner
Dec 16, 1998·Schizophrenia Bulletin·M De HertJ Peuskens
Dec 18, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·N BliedenC L Arfken
Feb 2, 1999·The British Journal of Psychiatry : the Journal of Mental Science·J M HaroJ L Vázquez-Barquero
Feb 25, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·M J SchillerW A Hargreaves
Jun 6, 1998·PharmacoEconomics·R H Foster, K L Goa
Jun 3, 1999·Annual Review of Public Health·P DiehrD Y Lin
Jul 2, 1999·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R GoereeP Goering
Jul 9, 1999·Statistics in Medicine·N T Longford
Oct 28, 1999·PharmacoEconomics·R H Foster, K L Goa
Nov 26, 1999·The Annals of Pharmacotherapy·C M HammondD S Pathak
Feb 2, 2000·European Archives of Psychiatry and Clinical Neuroscience·H Häfner, W an der Heiden
Jan 12, 2001·European Archives of Psychiatry and Clinical Neuroscience·W an der Heiden, H Häfner
Mar 17, 2001·Health Economics·A H Briggs, B J O'Brien
Apr 24, 2001·Journal of Public Health Medicine·S Limentani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here